Casanovas J M, Hervás I, Artigas F
Department of Neurochemistry, Instituto de Investigaciones Biomédicas de Barcelona, CSIC (IDIBAPS), Spain.
Neuroreport. 1999 May 14;10(7):1441-5. doi: 10.1097/00001756-199905140-00010.
5-HTt1A receptor agonists reduce the neuronal release of 5-hydroxytryptamine (5-HT) by activation of raphe 5-HT1A autoreceptors. Using in vivo microdialysis in unanesthetized rats, we show that the local application of the selective 5-HT1A receptor agonist 8-OH-DPAT decreased the 5-HT output to approximately 50% of controls in medial prefrontal cortex (mPFC) but not in dorsal hippocampus. The decrease in 5-HT output was counteracted by the concurrent application of the selective 5-HT1A receptor antagonist WAY-100635. This agent also reversed the decrease in 5-HT output elicited by the novel 5-HT1A receptor agonist BAY x 3702 (30 microM) in mPFC and dorsal raphe nucleus. These results indicate that postsynaptic 5-HT1A receptors in mPFC also participate in the control of serotonergic activity.
5-羟色胺1A(5-HTt1A)受体激动剂通过激活中缝5-HT1A自身受体来减少5-羟色胺(5-HT)的神经元释放。利用未麻醉大鼠的体内微透析技术,我们发现选择性5-HT1A受体激动剂8-羟基二丙胺基四氢萘(8-OH-DPAT)的局部应用使内侧前额叶皮质(mPFC)中的5-HT输出降低至对照组的约50%,但在背侧海马体中未出现这种情况。5-HT输出的降低被选择性5-HT1A受体拮抗剂WAY-100635的同时应用所抵消。该药物还逆转了新型5-HT1A受体激动剂BAY x 3702(30微摩尔)在mPFC和中缝背核中引起的5-HT输出降低。这些结果表明,mPFC中的突触后5-HT1A受体也参与了5-羟色胺能活性的调控。